• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院酒精及其他药物治疗中的心理困扰轨迹

Psychological Distress Trajectories in Residential Alcohol and Other Drug Treatment.

作者信息

Hatton Emma L, Kelly Peter J, Robinson Laura, Beck Alison, Lee Mei L, Stirling Robert, Mullaney Lauren, Campbell Michele, Larance Briony

机构信息

School of Psychology, University of Wollongong, Wollongong, Australia.

Network of Alcohol and Other Drug Agencies, Sydney, Australia.

出版信息

Drug Alcohol Rev. 2025 Jul;44(5):1308-1320. doi: 10.1111/dar.14099. Epub 2025 Jun 17.

DOI:10.1111/dar.14099
PMID:40528633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12228035/
Abstract

INTRODUCTION

Residential clients frequently report high psychological distress at intake, but little is known about changes in distress throughout treatment. This study aimed to identify in-treatment trajectories for psychological distress and factors associated with trajectory classes.

METHODS

A retrospective cohort of adults attending Australian non-government residential substance use treatment between 2012 and 2023 was identified from routinely collected data, NADAbase. Participants (N = 1492) completed ≥ 3 Kessler-10 Psychological Distress Scale (K10) assessments within 90 days of intake. Latent growth curve analyses identified classes of K10 trajectories. Multinomial regression identified demographic and clinical correlates (Severity of Dependence Scale [SDS] and EUROHIS Quality of Life scale [EQoL-8]) of class membership.

RESULTS

A five-class model describing K10 trajectories (1: moderate-low improved; 2: high-low improved; 3: very high-moderate improved; 4: very high-high improved; 5: very high unchanged) had the best model fit. Compared to high-low improved (34.5%; referent), moderate-low improved (45.4%) were less likely to identify as female, have higher SDS and lower EQoL-8 scores, or use cannabis; very high-moderate improved (13.1%) were more likely to have lower SDS scores, be aged under 25 and use opioids; very high-high improved (5.6%) were less likely to identify as male, be aged over 25, have higher EQoL and SDS scores; and very high unchanged (1.3%) were more likely to have lower EQoL scores and have left without completing treatment.

DISCUSSION AND CONCLUSIONS

Four K10 trajectory classes showed improvement after 90 days. Around 7% reported sustained high to very high psychological distress. Routine monitoring of psychological distress provides opportunities to identify non-improving clients and review treatment plans to improve outcomes.

摘要

引言

住院治疗的患者在入院时经常报告有高度的心理困扰,但对于整个治疗过程中困扰的变化情况却知之甚少。本研究旨在确定心理困扰的治疗期间轨迹以及与轨迹类别相关的因素。

方法

从常规收集的数据NADAbase中识别出2012年至2023年间在澳大利亚非政府住院物质使用治疗机构接受治疗的成年患者的回顾性队列。参与者(N = 1492)在入院后90天内完成了≥3次凯斯勒10项心理困扰量表(K10)评估。潜在增长曲线分析确定了K10轨迹的类别。多项回归确定了类别归属的人口统计学和临床相关因素(依赖严重程度量表[SDS]和欧洲生活质量量表[EQoL - 8])。

结果

一个描述K10轨迹的五类模型(1:中度 - 低度改善;2:高度 - 低度改善;3:非常高 - 中度改善;4:非常高 - 高度改善;5:非常高未改变)具有最佳的模型拟合度。与高度 - 低度改善组(34.5%;参照组)相比,中度 - 低度改善组(45.4%)女性身份认同的可能性较小,SDS得分较高,EQoL - 8得分较低,或使用大麻;非常高 - 中度改善组(13.1%)SDS得分较低、年龄在二十五岁以下且使用阿片类药物的可能性较大;非常高 - 高度改善组(5.6%)男性身份认同的可能性较小、年龄超过二十五岁且EQoL和SDS得分较高;非常高未改变组(1.3%)EQoL得分较低且未完成治疗就离开的可能性较大。

讨论与结论

四个K10轨迹类别在90天后显示出改善。约7%的人报告持续存在高至非常高的心理困扰。对心理困扰进行常规监测为识别未改善的患者并审查治疗计划以改善治疗效果提供了机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2394/12228035/ce0e96be7a14/DAR-44-1308-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2394/12228035/bd49b69ae20f/DAR-44-1308-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2394/12228035/ce0e96be7a14/DAR-44-1308-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2394/12228035/bd49b69ae20f/DAR-44-1308-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2394/12228035/ce0e96be7a14/DAR-44-1308-g002.jpg

相似文献

1
Psychological Distress Trajectories in Residential Alcohol and Other Drug Treatment.住院酒精及其他药物治疗中的心理困扰轨迹
Drug Alcohol Rev. 2025 Jul;44(5):1308-1320. doi: 10.1111/dar.14099. Epub 2025 Jun 17.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.创伤后应激障碍及共病物质使用障碍的心理治疗
Cochrane Database Syst Rev. 2016 Apr 4;4(4):CD010204. doi: 10.1002/14651858.CD010204.pub2.
4
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
5
Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.致幻剂辅助治疗对患有危及生命疾病的人群的焦虑、抑郁和存在性困扰的治疗作用。
Cochrane Database Syst Rev. 2024 Sep 12;9(9):CD015383. doi: 10.1002/14651858.CD015383.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
Topical anti-inflammatory treatments for eczema: network meta-analysis.外用抗炎治疗湿疹:网状荟萃分析。
Cochrane Database Syst Rev. 2024 Aug 6;8(8):CD015064. doi: 10.1002/14651858.CD015064.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
Sympathetic nerve blocks for persistent pain in adults with inoperable abdominopelvic cancer.成人无法手术的腹盆腔癌症持续性疼痛的交感神经阻滞。
Cochrane Database Syst Rev. 2024 Jun 6;6(6):CD015229. doi: 10.1002/14651858.CD015229.pub2.
10
Risk-stratified Care Improves Pain-related Knowledge and Reduces Psychological Distress for Low Back Pain: A Secondary Analysis of a Randomized Trial.风险分层护理可提高腰痛患者的疼痛相关知识并减轻心理困扰:一项随机试验的二次分析
Clin Orthop Relat Res. 2025 Apr 1;483(4):607-620. doi: 10.1097/CORR.0000000000003351. Epub 2025 Jan 21.

本文引用的文献

1
Women and opioid use disorder treatment: A scoping review of experiences, use of patient-reported experience measures, and integration of person-centred care principles.女性与阿片类药物使用障碍治疗:对经验、患者报告体验测量的使用以及以人为本的关怀原则整合的范围综述。
Int J Drug Policy. 2024 Aug;130:104520. doi: 10.1016/j.drugpo.2024.104520. Epub 2024 Jul 13.
2
Systematic review of treatment completion rates and correlates among young people accessing alcohol and other drug treatment.系统评价年轻人接受酒精和其他药物治疗的完成率及其相关因素。
Drug Alcohol Depend. 2024 Sep 1;262:111376. doi: 10.1016/j.drugalcdep.2024.111376. Epub 2024 Jun 30.
3
A systematic review on the effect of routine outcome monitoring and feedback on client outcomes in alcohol and other drug treatment.
关于在酒精和其他药物治疗中常规结果监测和反馈对客户结果影响的系统评价。
Drug Alcohol Rev. 2023 Nov;42(7):1701-1722. doi: 10.1111/dar.13742. Epub 2023 Aug 31.
4
Comparisons of psychological distress and self-stigma among three types of substance use disorders receiving treatment-as-usual approaches: real-world data from a 9-month longitudinal study.接受常规治疗的三种物质使用障碍患者的心理困扰与自我污名比较:一项为期9个月的纵向研究的真实世界数据
Ther Adv Chronic Dis. 2022 Dec 2;13:20406223221140393. doi: 10.1177/20406223221140393. eCollection 2022.
5
Statistical points and pitfalls: growth modeling.统计学要点与陷阱:生长模型
Perspect Med Educ. 2022 Mar;11(2):104-107. doi: 10.1007/s40037-022-00703-1. Epub 2022 Mar 16.
6
Evaluating an Aboriginal community controlled residential alcohol and other drug services: Use of benchmarking to examine within treatment changes in wellbeing.评估一个由原住民社区控制的住宿式酒精及其他药物服务机构:运用基准评估来审视治疗期间的幸福感变化。
Drug Alcohol Rev. 2022 May;41(4):953-962. doi: 10.1111/dar.13432. Epub 2022 Feb 1.
7
Abstinence versus moderation recovery pathways following resolution of a substance use problem: Prevalence, predictors, and relationship to psychosocial well-being in a U.S. national sample.物质使用问题解决后,禁欲与适度恢复途径:美国全国样本中的流行率、预测因素,以及与心理社会福祉的关系。
Alcohol Clin Exp Res. 2022 Feb;46(2):312-325. doi: 10.1111/acer.14765. Epub 2022 Jan 4.
8
Polysubstance use classes and health outcomes among women attending specialist substance use treatment services.在接受专科药物使用治疗服务的女性中,多物质使用类别与健康结果
Drug Alcohol Rev. 2022 Feb;41(2):488-500. doi: 10.1111/dar.13375. Epub 2021 Aug 18.
9
Evidence-Based Treatment of Young Adults With Substance Use Disorders.基于证据的物质使用障碍青年治疗。
Pediatrics. 2021 Jan;147(Suppl 2):S204-S214. doi: 10.1542/peds.2020-023523D.
10
Routine outcome measurement in specialist non-government alcohol and other drug treatment services: Establishing effectiveness indicators for the NADAbase.专科非政府酒精和其他药物治疗服务中的常规结果测量:为 NADAbase 建立有效性指标。
Drug Alcohol Rev. 2021 May;40(4):540-552. doi: 10.1111/dar.13191. Epub 2020 Nov 5.